ID   KUMCi001-A
AC   CVCL_ZX64
SY   ALLCD34+
DR   BioSamples; SAMEA3128119
DR   hPSCreg; KUMCi001-A
DR   Wikidata; Q102114441
RX   PubMed=32707488;
CC   From: Korea University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=32707488
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 23,24
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
RX   PubMed=32707488; DOI=10.1016/j.scr.2020.101913;
RA   Lee S.-J., Kang K.-W., Kim J.-H., Park Y., Kim B.-S.;
RT   "Generation of an induced pluripotent stem cell line KUMCi001-A from
RT   CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia
RT   using human placenta-derived cell conditioned medium.";
RL   Stem Cell Res. 47:101913-101913(2020).
//